Regarding combined effect of GST polymorphisms and hypertension on clear cell RCC risk, it seems that hypertension contributes to genotype-associated cRCC risk in all examined polymorphisms, once again with special emphasis on GSTM1-null and GSTP1-variant genotypes. Here, GSTM1 is linked to chromophobe renal cell carcinoma.